Hydrophilic-coated catheter appreciation study in a pediatric population

Andréanne Boucher1, Jonathan Cloutier, Sylvie Lebel

  • 1Division of Urology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC.

Insights

Hydrophilic-coated catheters (HC) were compared to uncoated catheters in pediatric patients with neurogenic bladder. While most preferred uncoated catheters, females using compact HC for urethral catheterization showed the most benefit.

Area of Science:

  • Urology
  • Pediatric Rehabilitation

Background:

  • Neurogenic bladder management in children often involves intermittent catheterization.
  • Hydrophilic-coated catheters (HC) aim to improve ease of use and reduce complications.
  • Patient satisfaction is a key factor in adherence to catheterization regimens.

Purpose of the Study:

  • To compare patient satisfaction with hydrophilic-coated (HC) versus uncoated catheters in a pediatric neurogenic bladder population.
  • To identify specific patient subgroups who may benefit from HC.
  • To test the hypothesis that pediatric patients with limitations might face difficulties using HC.

Main Methods:

  • A prospective comparative study was conducted in a pediatric rehabilitation center.
  • 31 patients/parents participated in a 1-week trial of HC after initial clinic assessment.
  • Data collected included patient demographics, neurological condition, dexterity, catheterization method, and satisfaction questionnaire responses.

Main Results:

  • 30 patients completed the satisfaction questionnaire; median age 13.5 years, 63% female, 87% self-catheterizing.
  • 10 children (33%) were willing to switch to HC, all for urethral catheterization.
  • Female patients using compact HC for urethral self-catheterization reported the most benefit and willingness to continue use.

Conclusions:

  • The majority of pediatric patients with neurogenic bladder preferred their usual uncoated catheters over HC.
  • Female patients performing urethral catheterization, particularly with compact HC, appear to be the primary beneficiaries.
  • Further research may be needed to optimize HC use in specific pediatric neurogenic bladder populations.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...